Hope for a Mad-Cow Therapy Is Seen in German Clinical Trial
Article Abstract:
Asta Medica, which is a unit of Frankfurt, Germany-based Degussa-Huels AG, is studying flupirtine as a therapy for mad-cow disease. The clinical trial is focusing on the human form of the disease, which is called Creutzfeldt-Jakob disease.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
New protocol: how drug's rebirth as treatment for cancer fueled price rises
Article Abstract:
Biotechnology company Celgene Corp. relaunched the drug thalidimide in 1998 to treat leprosy and severe weight loss caused by AIDS. At that time, the company priced the medication reasonably to avoid protests from AIDS activists. When Thalidimide was later reborn again, this time as a treatment for cancer patients, the company tripled its cost knowing that they were a lot less likely to receive negative publicity regarding a cancer drug.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Drug maker cuts risk by buying others' pills
Article Abstract:
To reduce research and development costs, pharmaceutical companies are buying, testing, and marketing experimental drugs developed by smaller pharmaceutical and biotech firms. Article discusses Shire PLC's management, earnings, and production and marketing strategies.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Pirelli wants to revisit terms for takeover of Telecom Italia. Pirelli rolls out new web strategy
- Abstracts: The Spanish market for ice cream, yoghurt and chilled desserts. The Italian market for ice cream, yoghurt and chilled desserts
- Abstracts: Accor's Shares Climb as Investors Cheer Its Sale of European Stake. NH Hoteles of Spain reports 1999 net income surged 150%
- Abstracts: Tempestuous times increase risks for unwary mutual-fund investors. Accenture will launch Jan.1
- Abstracts: Cybersquatting: European companies are not amused by spread of bogus coporate sites. Retailers' ultimate cool tool: the mobile phone